The 20th European AIDS Conference (EACS 2025), organized by the European AIDS Clinical Society (EACS), was held from October 15 to 18, 2025, at the Palais des Congrès in Paris, France.
The conference served as a platform for clinicians, researchers, community representatives, and activists to discuss advancements in HIV medicine, including the latest research, clinical updates, and insights on co-infections. It featured keynote and plenary lectures, oral presentations, posters, and symposia on topics such as HIV treatment pipelines, prevention strategies, epidemiology, and policy challenges in Europe.
Highlights included presentations on investigational HIV treatments like doravirine/islatravir and islatravir/lenacapavir, as well as data on long-acting therapies and PrEP options. The event was accredited with 17 European CME Credits (EACCME®).
